Speaker
Description
The accelerating emergence of antimicrobial resistance in animal production poses a growing threat to both veterinary medicine and public health worldwide, demanding innovative and sustainable alternatives to antibiotics.
Bacteriophages are viruses that specifically infect and lyse bacteria and are increasingly recognized as a natural and highly promising solution against pathogenic bacteria. Their unique biological features make them particularly well-suited for veterinary applications: they precisely target pathogenic bacteria, self-amplify at the site of infection, and spare the beneficial microbiota. Phages can be applied in multiple complementary ways: therapeutically to treat infections where antibiotics fail; preventively through biocontrol strategies that reduce bacterial load in herds and flocks; for biosanitation of farm environments and processing facilities; and in biopreservation to enhance the microbial safety and shelf life of animal-derived products.
Research and experimental studies have demonstrated phage efficacy against key bacterial pathogens in veterinary microbiology, including Escherichia coli, Salmonella enterica, Campylobacter spp., Clostridium perfringens, Pseudomonas aeruginosa, and Staphylococcus aureus, in both livestock and companion animals.
Phage-based approaches therefore represent a versatile, environmentally friendly alternative to antibiotics, with the potential to improve animal health, enhance food safety, and mitigate the public health risks associated with antimicrobial resistance.
| Registration ID | ECVM25-174 |
|---|---|
| Professional Status of the submitter, who is also the speaker | PhD Student |
Author
External references
- 51
